Mirum Pharmaceuticals, Inc. - common stock (MIRM) News
Filter MIRM News Items
MIRM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MIRM News Highlights
- MIRM's 30 day story count now stands at 2.
- Over the past 9 days, the trend for MIRM's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest MIRM News From Around the Web
Below are the latest news stories about MIRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate MIRM as an investment opportunity.
Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b Study for Biliary AtresiaFOSTER CITY, Calif., December 18, 2023--Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b Study for Biliary Atresia |
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)FOSTER CITY, Calif., December 09, 2023--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus ManagementDallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to announce the publication of its latest report, titled "Transformative Therapies for Pruritus Management." This comprehensive report delves into the critical issue of pruritus, or chronic itch, and its impact on patients, particularly those suffering from Primary Biliary Cholangitis (PBC), an autoimmune liver disease. ... |
Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx ConferenceFOSTER CITY, Calif., November 20, 2023--Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx Conference |
Mirum Pharmaceuticals Presents New Data at The Liver Meeting®FOSTER CITY, Calif., November 13, 2023--Mirum Pharmaceuticals Presents New Data at The Liver Meeting® |
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2023 Earnings Call TranscriptMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Good afternoon. I would like to welcome you all to the Mirum Pharmaceuticals Conference Call. My name is Brika and I’ll be the event specialist running today’s call with you. [Operator Instructions]. I would now like to pass the call over to […] |
Mirum Pharmaceuticals to Present at the 2023 UBS Biopharma ConferenceFOSTER CITY, Calif., November 03, 2023--Mirum Pharmaceuticals to Present at the 2023 UBS Biopharma Conference |
Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateFOSTER CITY, Calif., November 02, 2023--Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update |
NeoGenomics (NEO) Expected to Beat Earnings Estimates: Should You Buy?NeoGenomics (NEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Mirum Pharmaceuticals to Present New Data at The Liver Meeting®FOSTER CITY, Calif., October 30, 2023--Mirum Pharmaceuticals to Present New Data at The Liver Meeting® |